Cell-based therapies have become integral to the routine clinical management of hematologic malignancies. Tumor-infiltrating lymphocyte (TIL) therapy has demonstrated efficacy in immunogenic solid tumors, such as melanoma. However, in the GI field, …
Maurie Markman, MD, delves into questions regarding precision medicine and genetic testing in cancer.
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Submit an abstract to the AACR IO 2025, February 23-26, 2025, in Los Angeles. This new major conference will encompass the very best of basic,…
Key PointsFunction of antifibrinolytic protein α2AP can be modulated using Affimers, facilitating lysis of clots from plasma and whole blood samples.α2AP-s
We say thank you to current Cancer Stories host, Dr. Lidia Schapira, and welcome Cancer Stories new host, Dr. Mikkael Sekeres.
Jennifer A. Woyach, a blood cancer doctor and researcher who has been with Ohio State for more than 12 years, was named director of the…
Elinzanetant reduced vasomotor symptoms frequency and severity in women with or at high risk of HR-positive breast cancer in the OASIS 4 trial.
Everolimus plus lanreotide elicited a PFS of 29.7 months compared with 11.5 months from everolimus monotherapy in patients with gastroenteropancreatic neuroendocrine tumors.
A healthy diet can cut your risk for cancer and other chronic diseases. But where should you start?
